60 related articles for article (PubMed ID: 15161018)
21. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
Triller N; Korosec P; Kern I; Kosnik M; Debeljak A
Lung Cancer; 2006 Nov; 54(2):235-40. PubMed ID: 16934363
[TBL] [Abstract][Full Text] [Related]
22. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance].
Zhang JB; Sun Y; Dong J; Liu LX; Ning F
Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
Munteanu E; Verdier M; Grandjean-Forestier F; Stenger C; Jayat-Vignoles C; Huet S; Robert J; Ratinaud MH
Biochem Pharmacol; 2006 Apr; 71(8):1162-74. PubMed ID: 16499877
[TBL] [Abstract][Full Text] [Related]
24. [Multidrug resistance markers monitoring in acute myeloid leukemia cells].
Jankovicová K; Krejsek J; Kopecký O; Voglová J; Novosad J
Cas Lek Cesk; 2004; 143(7):471-5. PubMed ID: 15373290
[TBL] [Abstract][Full Text] [Related]
25. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
Huffman KE; Corey DR
Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
[TBL] [Abstract][Full Text] [Related]
26. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
27. Specific inhibition of gene expression of lung resistance-related protein by short interfering RNA.
Li N; Qian XH; Wang ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):1-5. PubMed ID: 16495165
[TBL] [Abstract][Full Text] [Related]
28. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Stein U; Bergmann S; Scheffer GL; Scheper RJ; Royer HD; Schlag PM; Walther W
Oncogene; 2005 May; 24(22):3606-18. PubMed ID: 15750632
[TBL] [Abstract][Full Text] [Related]
29. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
30. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
32. P-glycoprotein activity in renal clear cell carcinoma.
Soto-Vega E; Arroyo C; Richaud-Patin Y; García-Carrasco M; Vázquez-Lavista LG; Llorente L
Urol Oncol; 2009; 27(4):363-6. PubMed ID: 18440836
[TBL] [Abstract][Full Text] [Related]
33. Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP.
Ugocsai K; Varga A; Molnár P; Antus S; Molnár J
In Vivo; 2005; 19(2):433-8. PubMed ID: 15796208
[TBL] [Abstract][Full Text] [Related]
34. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression.
Oda Y; Ohishi Y; Basaki Y; Kobayashi H; Hirakawa T; Wake N; Ono M; Nishio K; Kuwano M; Tsuneyoshi M
Cancer Sci; 2007 Jul; 98(7):1020-6. PubMed ID: 17459055
[TBL] [Abstract][Full Text] [Related]
36. Assay for determination of daunorubicin in cancer cells with multidrug resistance phenotype.
Krumpochova P; Kocurova A; Dolezel P; Mlejnek P
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1875-80. PubMed ID: 21641880
[TBL] [Abstract][Full Text] [Related]
37. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R
Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922
[TBL] [Abstract][Full Text] [Related]
39. Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.
Gerrard G; Payne E; Baker RJ; Jones DT; Potter M; Prentice HG; Ethell M; McCullough H; Burgess M; Mehta AB; Ganeshaguru K
Haematologica; 2004 Jul; 89(7):782-90. PubMed ID: 15257929
[TBL] [Abstract][Full Text] [Related]
40. The drug resistance-related protein LRP is the human major vault protein.
Scheffer GL; Wijngaard PL; Flens MJ; Izquierdo MA; Slovak ML; Pinedo HM; Meijer CJ; Clevers HC; Scheper RJ
Nat Med; 1995 Jun; 1(6):578-82. PubMed ID: 7585126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
